Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/EBIT(x) 26.9127.3647.7027.698.47

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 26.91 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar202626.91
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2026 26.91
-1.64
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,477.6 Cr -2.5% 5.6% 27.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹112,773.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -0.9% -1.8% -9.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.5%

5.6%

27.5%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses